Literature DB >> 33022389

3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing.

Ilias El Aita1, Jhinuk Rahman2, Jörg Breitkreutz1, Julian Quodbach3.   

Abstract

The establishment of 3D-printing as manufacturing process for oral solid dosage forms enables new options for the individualized medicine. The aim of this work was to develop a novel drug-printing model using pressure-assisted microsyringe (PAM) technology, which allows the precise dispensing of drug substances. Printed tablets with different numbers of layers, mimicking different doses for pediatric subgroups, were analyzed regarding mass variation, friability, thickness and disintegration time. Furthermore, the uniformity of dosage units and the dissolution behavior were investigated. Friability was <0.3% in all cases, which demonstrates the ability of PAM printing to manufacture robust solid dosage. Disintegration results showed the dependency of the disintegration on the number of layers and therefore on the compact mass of polymer. However, all tablets disintegrated within 3 min and fulfilled the requirements of immediate release tablets of the USP and orodispersible tablets according to the Ph. Eur. Results of uniformity dosage units confirmed the successful manufacturing of the intended individualized doses. Drug dissolution appeared to be dependent on the number of layers. An increase of layers resulted in a decrease of the drug release rate. Further, the drug release could be correlated to the surface area/volume (SA/V) ratio.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D-printing; Immediate release; Individualized medicine; Levetiracetam; Paediatrics; Pressure-assisted microsyringe (PAM); Semi solid extrusion

Mesh:

Substances:

Year:  2020        PMID: 33022389     DOI: 10.1016/j.ejpb.2020.09.012

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  3D Printed Mini-Floating-Polypill for Parkinson's Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy.

Authors:  Hellen Windolf; Rebecca Chamberlain; Jörg Breitkreutz; Julian Quodbach
Journal:  Pharmaceutics       Date:  2022-04-25       Impact factor: 6.525

Review 2.  3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?-A Scoping Review.

Authors:  Iris Lafeber; Elisabeth J Ruijgrok; Henk-Jan Guchelaar; Kirsten J M Schimmel
Journal:  Pharmaceutics       Date:  2022-02-14       Impact factor: 6.321

3.  'Tablet-in-Syringe': A Novel Dosing Mechanism for Dysphagic Patients Containing Fast-Disintegrating Tablets Fabricated Using Semisolid Extrusion 3D Printing.

Authors:  Pattaraporn Panraksa; Bin Zhang; Pornchai Rachtanapun; Kittisak Jantanasakulwong; Sheng Qi; Pensak Jantrawut
Journal:  Pharmaceutics       Date:  2022-02-18       Impact factor: 6.321

Review 4.  Additive Manufacturing Strategies for Personalized Drug Delivery Systems and Medical Devices: Fused Filament Fabrication and Semi Solid Extrusion.

Authors:  Giulia Auriemma; Carmela Tommasino; Giovanni Falcone; Tiziana Esposito; Carla Sardo; Rita Patrizia Aquino
Journal:  Molecules       Date:  2022-04-27       Impact factor: 4.411

Review 5.  Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.

Authors:  Andreea Cornilă; Sonia Iurian; Ioan Tomuță; Alina Porfire
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

Review 6.  Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics.

Authors:  Guendalina Zuccari; Silvana Alfei; Danilo Marimpietri; Valentina Iurilli; Paola Barabino; Leonardo Marchitto
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.